Viktor Grut

9PUBLICATIONS
10CO-AUTHORS
Medical infection agents (incl. prions)Environmental epidemiologyNanotoxicology, health and safetyPeripheral nervous systemReaction kinetics and dynamics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 20, 2026
Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosis.

|Jan 12, 2026
Human herpesvirus 7 and the risk of developing multiple sclerosis.

Jens Ingvarsson, Viktor Grut, Rasmus Gustafsson

|Jul 18, 2024
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis.

Jens Ingvarsson, Viktor Grut, Martin Biström

|Jun 11, 2024
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control Study.

Viktor Grut, Martin Biström, Jonatan Salzer

|Nov 06, 2023
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis.

Viktor Grut, Martin Biström, Jonatan Salzer

|Oct 06, 2023
Seroreactivity against lytic, latent and possible cross-reactive EBV antigens appears on average 10 years before MS induced preclinical neuroaxonal damage.

Daniel Jons, Viktor Grut, Tomas Bergström

Pageof 2

Frequent Collaborators

6 joint publications

Martin Biström

4 joint publications

Daniel Jons

3 joint publications

Ingrid Kockum

3 joint publications

Jens Ingvarsson